SEC Company Response from Bioquest Corp (BQST) (CIK 0001568628) (BQST) — May 20, 2020
Bioquest Corp (BQST) (CIK 0001568628)
Date: May 20, 2020 · CIK: 0001568628 · Accession: 0001493152-20-009494
AI Filing Summary & Sentiment
File numbers found in text: 024-11151
Letter
Division of Corporation Finance Office of Technology United States Securities and Exchange Commission Filed: February 11, 2020 Response Dated: March 18, 2020 File No. 024-11151 May 20, 2020
Dear Mr. Derby,
This letter sets forth the request of BioQuest Corp., (“BQST” or the “Company”) for Qualification of its Regulation A Offering.
Kindly be advised that BioQuest Corp. (the “Company”) requests that its Regulation A offering be qualified on Friday, May 22, 2020 at 12pm.
In connection with the foregoing request, the Company hereby confirms and acknowledges that:
1. should the Commission or the staff, acting pursuant to delegated authority, qualify the filing, it does not foreclose the Commission from taking any action with respect to the filing;
2. the action of the Commission or the staff, acting pursuant to delegated authority, in qualifying the filing, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
3. the Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
We trust the foregoing is in order.
If you have any questions or require any additional information with respect to the above, please do not hesitate to contact me at (714) 978-4425 or Andrew Coldicutt of the Law Office of Andrew Coldicutt at (619) 228-4970. Thank you for your attention to this matter.
BioQuest Corp.
/s/Thomas Hemingway
Name: Thomas Hemingway
Title: Chief Executive Officer, Director
Show Raw Text
CORRESP
1
filename1.htm
BioQuest
Corp.
3700
Campus Drive, Suite 206
Newport
Beach, CA 92660
Phone:
(714) 978-4425
Matthew
Derby
Division
of Corporation Finance
Office
of Technology
United
States Securities and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Re:
BioQuest
Corp.
Offering
Statement on Form 1-A
Filed:
February 11, 2020
Response
Dated: March 18, 2020
File
No. 024-11151
May
20, 2020
Dear
Mr. Derby,
This
letter sets forth the request of BioQuest Corp., (“BQST” or the “Company”) for Qualification of its Regulation
A Offering.
Kindly
be advised that BioQuest Corp. (the “Company”) requests that its Regulation A offering be qualified on Friday, May
22, 2020 at 12pm.
In
connection with the foregoing request, the Company hereby confirms and acknowledges that:
1.
should
the Commission or the staff, acting pursuant to delegated authority, qualify the filing, it does not foreclose the Commission
from taking any action with respect to the filing;
2.
the
action of the Commission or the staff, acting pursuant to delegated authority, in qualifying the filing, does not relieve
the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
3.
the
Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any
person under the federal securities laws of the United States.
We
trust the foregoing is in order.
If
you have any questions or require any additional information with respect to the above, please do not hesitate to contact me at
(714) 978-4425 or Andrew Coldicutt of the Law Office of Andrew Coldicutt at (619) 228-4970. Thank you for your attention to this
matter.
BioQuest Corp.
/s/Thomas
Hemingway
Name:
Thomas
Hemingway
Title:
Chief
Executive Officer, Director